Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations

Nutrition and Cancer
Helen L RobbinsMartin O Weickert

Abstract

Vitamin D (vit-D) deficiency is highly prevalent in patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NET) and has been linked to reduced overall survival. We here assessed the vit-D status in 183 patients with GEP-NET at the time of their first presentation in the ARDEN NET Centre. We further examined the effect of simple advice to increase vit-D intake using over-the-counter vit-D preparations [colecalciferol (Vit-D3), 1,000-2,000 units/day], over a prospective observation period of 24 mo. At baseline, only 33.3% of patients showed vit-D sufficiency (25-OH-vit-D; >50 nmol/L), the remainder was insufficient (31.3%; 25-OH-vit-D; 25-50 nmol/L) or deficient (35.5%; 25-OH-vit-D; <25 nmol/L). Repeated advice to increase vit-D intake at routine 6-monthly follow-up appointments was associated with increased 25-OH-vit-D from 37.8 ± 3.5 nmol/L at baseline to 60.4 ± 5.6 nmol/L (P < 0.0001) and 56.8 ± 7.0 nmol/L (P = 0.039) after 12 and 24 mo. Percentage of vit-D insufficiency decreased from 66.6% at baseline to 44.9% and 46.2% after 12 and 24 months, respectively. Previous abdominal surgery, but not treatment with somatostatin analogues predicted 25-OH-vit-D levels in bootstrapped linear regression analyses (P = 0.037). ...Continue Reading

References

Jul 11, 2006·The American Journal of Clinical Nutrition·Heike A Bischoff-FerrariBess Dawson-Hughes
Sep 13, 2006·Virchows Archiv : an International Journal of Pathology·G RindiUNKNOWN European Neuroendocrine Tumor Society (ENETS)
Mar 9, 2007·The American Journal of Clinical Nutrition·Elina Hyppönen, Chris Power
Mar 20, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Daniel D Bikle
Nov 26, 2009·Age and Ageing·Vasant HiraniJennifer Mindell
Jan 13, 2010·BMJ : British Medical Journal·Simon H S Pearce, Tim D Cheetham
Mar 17, 2010·The American Journal of Geriatric Pharmacotherapy·Karen Barnard, Cathleen Colón-Emeric
Nov 6, 2010·Alimentary Pharmacology & Therapeutics·H-B FiebrichE G E De Vries
Apr 18, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·U AlamR A Malik
Aug 5, 2014·The Journal of Steroid Biochemistry and Molecular Biology·Doris HummelHenrik Csaba Horváth
Feb 26, 2016·British Journal of Nursing : BJN·Louise Davies, Martin O Weickert
Mar 31, 2016·European Journal of Clinical Nutrition·A LindL Ellegård
Sep 9, 2016·The American Journal of Clinical Nutrition·Simonette R MallardLisa A Houghton
May 10, 2017·Epidemiologic Reviews·Alison M MondulDemetrius Albanes

❮ Previous
Next ❯

Citations

May 21, 2020·Nutrients·Jakub PobłockiMałgorzata Szczuko
Mar 20, 2019·World Journal of Gastroenterology : WJG·Dominique Svm ClementJohn K Ramage

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
ELISA
small
bowel bypass

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Carcinoma, Islet Cell

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arises in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Carcinoma here.

Carcinoma, Islet Cell (Keystone)

Islet Cell Carcinoma or Pancreatic Neuroendocrine Tumours arise in the hormone producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on islet cell carcinoma in this feed.

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.